亚星化学(600319) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was ¥188,382,789.11, representing a decrease of 7.83% compared to the same period last year[5] - In Q1 2024, the overall sales revenue of the company decreased by 7.83% year-on-year, primarily due to intense market competition and seasonal factors affecting CPE and caustic soda products, which saw a combined sales revenue decline of 13.66%[13] - Total operating revenue for Q1 2024 was ¥188,382,789.11, a decrease of 7.3% compared to ¥204,381,878.99 in Q1 2023[19] - Net loss for Q1 2024 was ¥35,368,169.89, compared to a net loss of ¥18,676,929.94 in Q1 2023, representing an increase in loss of 89.5%[20] - Basic and diluted earnings per share for Q1 2024 were both -¥0.09, compared to -¥0.05 in Q1 2023[20] Assets and Liabilities - Total assets at the end of Q1 2024 were ¥2,134,510,322.16, an increase of 1.05% from the end of the previous year[6] - Total assets increased to ¥2,134,510,322.16 in Q1 2024 from ¥2,112,367,105.54 in Q1 2023, reflecting a growth of 1.0%[17] - Total liabilities rose to ¥1,522,398,808.89 in Q1 2024, compared to ¥1,464,887,422.38 in Q1 2023, marking an increase of 3.9%[17] - Shareholders' equity attributable to the parent company decreased by 5.45% to ¥608,950,903.34 compared to the end of the previous year[6] - Non-current liabilities decreased slightly to ¥316,358,246.95 in Q1 2024 from ¥325,776,299.46 in Q1 2023[17] Cash Flow - Cash inflow from operating activities totaled $197.55 million, an increase from $187.10 million year-over-year[23] - Net cash outflow from operating activities was $12.93 million, improving from a loss of $24.73 million in the previous year[23] - The company reported a total cash outflow of $210.49 million from operating activities, slightly down from $211.84 million year-over-year[23] - Cash inflow from investment activities was $0.06 million, down from $4.82 million year-over-year[23] - Cash inflow from financing activities amounted to $347.38 million, a decrease from $441.20 million year-over-year[23] Operational Highlights - The company reported a significant increase in prepayments by 41.68% due to higher raw material payments[8] - Other receivables rose by 81.18%, primarily due to an increase in financing lease deposits by ¥4.6 million[8] - The company experienced a 222.16% increase in notes payable, attributed to the issuance of acceptance bills for project payments[8] - The company introduced a new hydrogen peroxide product, contributing an additional sales revenue of 10 million RMB during the reporting period[13] - The company is currently constructing a 12,000 tons/year hydrazine hydrate project, with 85% completion of the main structure assembly as of the report date[13] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 18,007[10] - The company plans to invest in a new facility for a 45,000 tons/year high-end new materials project, which was approved by the shareholders' meeting[14] Financial Expenses - Financial expenses surged to ¥21,111,057.95 in Q1 2024, up from ¥9,589,135.61 in Q1 2023, indicating a significant increase in interest expenses[19] Other Financial Information - The company’s total current assets as of March 31, 2024, were 304,580,179.55 RMB, compared to 298,454,823.62 RMB at the end of 2023[15] - The company reported a decrease in goodwill and intangible assets, with intangible assets at ¥280,015,209.32 in Q1 2024, down from ¥283,230,696.98 in Q1 2023[16] - The company’s total liabilities and equity figures will be disclosed in the complete financial report, which is currently under preparation[15] - As of March 31, 2024, the company's cash and cash equivalents amounted to 39,051,276.17 RMB, a decrease from 40,505,566.64 RMB at the end of 2023[15]